Results 91 to 100 of about 339,620 (340)

Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients

open access: yesRenal Failure, 2019
Background: Soluble transferrin receptor (sTfR) is a biomarker of erythropoiesis, which is often impaired in dialysis patients. The aim of our study was to evaluate sTfR levels in chronically dialyzed patients and assess potential determinants of its ...
Luís Belo   +12 more
doaj   +1 more source

Comparison of Gabapentin and Ketotifen in Treatment of Uremic Pruritus in Hemodialysis Patients [PDF]

open access: green, 1969
Saeid Amirkhanlou   +4 more
openalex   +1 more source

Synchronous Bilateral Large Renal Cell Carcinoma Treated With Presurgical Pembrolizumab and Lenvatinib Enabling Unilateral Partial Nephrectomy and Dialysis Avoidance: A Case Report

open access: yesIJU Case Reports, EarlyView.
ABSTRACT Introduction Synchronous bilateral renal cell carcinoma is a rare clinical entity that poses considerable challenges in establishing an optimal treatment strategy. Case Presentation A 56‐year‐old woman had synchronous bilateral renal cell carcinoma, with tumors in the right (61 mm) and left (71 mm) kidneys.
Hiroki Kawabata   +6 more
wiley   +1 more source

Outcomes of ABO-incompatible kidney transplants with very high isoagglutinin titers: a single-center experience and literature review

open access: yesFrontiers in Immunology
BackgroundABO-incompatible kidney transplantation (ABOi-KTx) represents a possible solution to address the shortage of kidney donors. However, these transplants present immunological challenges, particularly when isoagglutinin titers are elevated ...
Hamza Naciri Bennani   +7 more
doaj   +1 more source

Effect of Hemodialysis on Total and Free Lenvatinib Concentrations in a Patient With Metastatic Renal Cell Carcinoma

open access: yesIJU Case Reports, EarlyView.
ABSTRACT Introduction Lenvatinib (LEN) concentrations in patients undergoing hemodialysis (HD) have not been examined. Herein, we report the effect of HD on total and free LEN concentrations in a patient with mRCC. Case Presentation The hemodialyzed patient was a 55‐year‐old Japanese male who was treated with 20 mg LEN daily.
Takahiro Ito   +5 more
wiley   +1 more source

POS-700 PREGNANCY IN KIDNEY TRANSPLANT RECIPIENTS: EFFECTS ON MOTHER AND CHILD

open access: yesKidney International Reports, 2021
M. MOJAAT   +8 more
doaj   +1 more source

Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose

open access: yesMicroorganisms
Monoclonal antibodies have been administered to kidney transplant recipients (KTRs) with a poor or non-responder status to SARS-CoV-2 vaccination. The cellular response to SARS-CoV-2 has been poorly studied in this context.
Dominique Bertrand   +12 more
doaj   +1 more source

Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment

open access: yesThe Journal of Clinical Pharmacology, EarlyView.
Abstract The neurokinin 3 receptor antagonist fezolinetant is an approved treatment for vasomotor symptoms due to menopause. The impacts of hepatic and renal impairment on the pharmacokinetics and safety of a single oral dose of fezolinetant 30 mg were investigated in two independent studies.
Megumi Iwai   +8 more
wiley   +1 more source

POS-698 VARICELLA ZOSTER VIRUS IN TRANSPLANT RECIPIENTS: A SINGLE CENTER STUDY

open access: yesKidney International Reports, 2021
M. MOJAAT   +8 more
doaj   +1 more source

Augmented Cardiopulmonary Baroreflex Sensitivity in Intradialytic Hypertension. [PDF]

open access: yes, 2018
IntroductionEnd-stage renal disease (ESRD) patients with a paradoxical increase in blood pressure (BP) during hemodialysis (HD), termed intradialytic hypertension (ID-HTN), are at significantly increased risk for mortality and adverse cardiovascular ...
DaCosta, Dana R   +5 more
core  

Home - About - Disclaimer - Privacy